DE3752376D1 - Verfahren zur Anwendung den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren - Google Patents

Verfahren zur Anwendung den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren

Info

Publication number
DE3752376D1
DE3752376D1 DE3752376T DE3752376T DE3752376D1 DE 3752376 D1 DE3752376 D1 DE 3752376D1 DE 3752376 T DE3752376 T DE 3752376T DE 3752376 T DE3752376 T DE 3752376T DE 3752376 D1 DE3752376 D1 DE 3752376D1
Authority
DE
Germany
Prior art keywords
expression vectors
vectors containing
eukaryotic expression
virus enhancer
enhancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3752376T
Other languages
English (en)
Inventor
Brian William Grinnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE3752376D1 publication Critical patent/DE3752376D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3752376T 1986-04-09 1987-04-09 Verfahren zur Anwendung den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren Expired - Lifetime DE3752376D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84999986A 1986-04-09 1986-04-09

Publications (1)

Publication Number Publication Date
DE3752376D1 true DE3752376D1 (de) 2004-10-14

Family

ID=25307027

Family Applications (3)

Application Number Title Priority Date Filing Date
DE3752376T Expired - Lifetime DE3752376D1 (de) 1986-04-09 1987-04-09 Verfahren zur Anwendung den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
DE3752134T Expired - Fee Related DE3752134T2 (de) 1986-04-09 1987-04-09 Verfahren zur Anwendung von den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
DE3752382T Expired - Fee Related DE3752382T2 (de) 1986-04-09 1987-04-09 Verfahren zur Anwendung von der BK-Virus Verstärker enthaltenden eukaryotischer Expressionsvektoren

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE3752134T Expired - Fee Related DE3752134T2 (de) 1986-04-09 1987-04-09 Verfahren zur Anwendung von den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
DE3752382T Expired - Fee Related DE3752382T2 (de) 1986-04-09 1987-04-09 Verfahren zur Anwendung von der BK-Virus Verstärker enthaltenden eukaryotischer Expressionsvektoren

Country Status (11)

Country Link
EP (3) EP0584845B1 (de)
JP (5) JP3162056B2 (de)
AU (1) AU605479B2 (de)
CA (2) CA1318619C (de)
DE (3) DE3752376D1 (de)
DK (1) DK176387A (de)
ES (3) ES2237755T3 (de)
HK (2) HK1009605A1 (de)
HU (1) HU211391B (de)
IE (3) IE980257A1 (de)
IL (5) IL98887A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613481D0 (en) * 1986-06-04 1986-07-09 Diatech Ltd Translation of mrna
KR102069561B1 (ko) * 2013-07-11 2020-01-23 다카라 바이오 가부시키가이샤 외피 비보유 바이러스의 제조 방법
WO2015118146A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production
WO2016006658A1 (ja) 2014-07-10 2016-01-14 タカラバイオ株式会社 非エンベロープウイルス粒子の製造方法
EP3243904A4 (de) 2015-01-09 2018-06-27 Takara Bio Inc. Verfahren zur herstellung von unbehüllten viruspartikeln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
JPH0789930B2 (ja) * 1984-03-08 1995-10-04 大正製薬株式会社 ウイルス性転写促進配列
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
JPH02502605A (ja) * 1987-03-13 1990-08-23 シェリング・コーポレーション 遺伝子発現の刺激方法
JPH0660120A (ja) * 1992-08-06 1994-03-04 Sharp Corp 可変長データの格納方法及び検索装置

Also Published As

Publication number Publication date
ES2227514T3 (es) 2005-04-01
ES2237755T3 (es) 2005-08-01
IL98887A (en) 1992-12-01
HUT43633A (en) 1987-11-30
JP2958286B2 (ja) 1999-10-06
DK176387A (da) 1987-11-13
IL98886A (en) 1992-12-01
DK176387D0 (da) 1987-04-07
IE870912L (en) 1987-10-09
EP0699764A1 (de) 1996-03-06
CA1318619C (en) 1993-06-01
AU605479B2 (en) 1991-01-17
EP0584845A1 (de) 1994-03-02
CA1340384C (fr) 1999-02-09
IL98887A0 (en) 1992-07-15
IE81065B1 (en) 2000-01-12
JP3162056B2 (ja) 2001-04-25
EP0699764B1 (de) 2005-03-09
JPS6312296A (ja) 1988-01-19
DE3752134T2 (de) 1998-03-19
IL82093A (en) 1992-12-01
JPH1057081A (ja) 1998-03-03
JP2001145496A (ja) 2001-05-29
IL82093A0 (en) 1987-10-30
IL98886A0 (en) 1992-07-15
ES2107997T3 (es) 1997-12-16
HU211391B (en) 1995-11-28
IE980258A1 (en) 1987-10-09
DE3752382T2 (de) 2005-12-29
DE3752382D1 (de) 2005-04-14
EP0576049A1 (de) 1993-12-29
DE3752134D1 (de) 1997-12-04
HK1021861A1 (en) 2000-07-07
JP2877228B2 (ja) 1999-03-31
HK1009605A1 (en) 1999-06-04
JPH099980A (ja) 1997-01-14
JPH11346789A (ja) 1999-12-21
AU7117587A (en) 1987-10-15
EP0584845B1 (de) 2004-09-08
IE980257A1 (en) 1987-10-09

Similar Documents

Publication Publication Date Title
DE59303220D1 (de) Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton
DE3752376D1 (de) Verfahren zur Anwendung den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
DE69314899D1 (de) Verfahren zur Herstellung von Polyaminoborazinen
DE69315297D1 (de) Verfahren zur Herstellung von Omega-Alkenylchlorsilanen
DE69325079T2 (de) Verfahren zur Herstellung von Triorganochlorsilane
DE69303057D1 (de) Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin
DE69316300T2 (de) Verfahren zur Herstellung von cyclischen Organohydrosiloxanen
DE59301311D1 (de) Verfahren zur Herstellung von Perfluoralkylsulfonylfluoriden sowie Elektroden zur Durchführung des Verfahrens
DE69315317D1 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE69321661T2 (de) Verfahren zur Herstellung von Triorganomonohalogensilan
DE69318765D1 (de) Verfahren zur Herstellung von Hydridoorganooxysilanen
DE59306312D1 (de) Verbessertes Verfahren zur Herstellung von cyclischen Acetalen von 3-formyl-2-butenyl-triphenylphosphoniumchlorid
DE59301629D1 (de) Verfahren zur Herstellung von Thixotropiermitteln
DE59306959D1 (de) Verfahren zur Herstellung von Difluor- und Chlorfluorbenzodioxolen
DE69308193T2 (de) Verfahren zur Herstellung von Alpha-L-Aspartyl-L-Phenylalanin
DE69305279T2 (de) Verfahren zur Herstellung von Dimethyltetralin
DE59304663D1 (de) Verfahren zur Herstellung von 4-Hydroxymethyltetrahydropyran
DE69322893T2 (de) Verfahren zur Herstellung von Epsilon-poly-L-Lysin
PT75124A (de) Verfahren zur herstellung von heteroaryl-und dibenzoxepinaalkansauren
DE69315979T2 (de) Verfahren zur Herstellung von 1-Phenoxy-2-aminopropan
DE59310105D1 (de) Verfahren zur Herstellung von 2-Amino-5-methyl-pyridin
DE69303656D1 (de) Verfahren zur Herstellung von 2-Oxytetrahydrofurane
DE69316321D1 (de) Verfahren zur Herstellung von Methylalpha-Hydroxyisobutyrat
DE59309728D1 (de) Verfahren zur Herstellung von Diorganozinnmercaptocarboxylaten
DE69301345D1 (de) Verfahren zur Herstellung von 4-Deoxy-D-Mannose

Legal Events

Date Code Title Description
8330 Complete renunciation